FDA Drug Application (206406) for ENVARSUS XR by VELOXIS PHARMS INC

Back to FDA Applications sponsored by VELOXIS PHARMS INC

Application Number206406
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
DosageEQ 0.75MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameENVARSUS XR
Active IngredientTACROLIMUS

Active IngredientCount
List of drugs with Active Ingredient TACROLIMUS5


Back to FDA Applications sponsored by VELOXIS PHARMS INC